Online citations, reference lists, and bibliographies.

Effect Of Adherence To Antihypertensive Medication On The Long-Term Outcome After Hemorrhagic Stroke In Korea

Jinkwon Kim, Cheryl D Bushnell, Hye Sun Lee, Sang Won Han
Published 2018 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Hypertension is the single most important risk factor for hemorrhagic stroke, a leading cause of mortality and disability worldwide. Adherence to antihypertensive medication is essential to achieving strict blood pressure control, but poor adherence is common in clinical practice. We evaluated adherence to antihypertensive medication in patients with acute hemorrhagic stroke and its effects on long-term outcome. This was a retrospective cohort study based on a nationwide health insurance claims database in South Korea. We included 1872 hypertensive patients who were admitted with acute hemorrhagic stroke during 2002 to 2013 (1354 cases of intracerebral hemorrhage and 518 cases of subarachnoid hemorrhage). Adherence to antihypertensive medication was calculated using the proportion of days covered by any antihypertensive medication throughout the follow-up period (categorized into poor <40%; intermediate 40%–80%; good >80%) and treated as a time-dependent variable. Primary outcome was defined as a composite of recurrent stroke (hemorrhagic or ischemic), myocardial infarction, or all-cause mortality. Time-dependent Cox proportional hazard regression analyses were performed. During the mean follow-up period of 4.45 years, 634 patients had the primary outcome. The proportion of patients with good adherence to antihypertensive medication was 46.8% at 1 year, 43.2% at 3 years, and 41.7% at 5 years of follow-up. Compared with good adherence, the adjusted hazard ratio (95% confidence interval) for the primary outcome was 1.80 (1.49–2.16) for poor adherence and 1.56 (1.27–1.93) for intermediate adherence.
This paper references
10.1161/STROKEAHA.112.663047
Poor Long-Term Blood Pressure Control After Intracerebral Hemorrhage
Darin B. Zahuranec (2012)
10.1038/sj.jhh.1002046
Does it matter whether patients take their antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control
Jonathan Mant (2006)
10.1161/HYPERTENSIONAHA.116.08485
Blood Pressure Reduction and Secondary Stroke Prevention: A Systematic Review and Metaregression Analysis of Randomized Clinical Trials
Aristeidis H Katsanos (2017)
10.1093/eurheartj/ehi705
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
Gunnar H. Gislason (2006)
ASTRA Study Group. Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain. 2005;128(pt 10):2421–2429
MJ Wermer (2005)
10.1159/000177034
Six-Year Survival and Causes of Death among Stroke Patients in Korea
Hyeon Chang Kim (2008)
The Accuracy of ICD codes for Cerebrovascular Diseases in Medical Insurance Claims
Jong Ku Park (2000)
10.1161/CIRCULATIONAHA.109.906164
Impact of nonadherence to antihypertensive therapy.
Aram V. Chobanian (2009)
10.1161/STROKEAHA.109.563932
Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
Hisatomi Arima (2010)
Blood pressure lowering for prevention of cardiovascular disease and death : a systematic review and meta - analy
SS Yoon (2016)
10.1016/S0140-6736(98)03454-0
Blood pressure, cholesterol, and stroke in eastern Asia
Anthony Rodgers (1998)
10.1161/STROKEAHA.117.018140
Effects of Statin Intensity and Adherence on the Long-Term Prognosis After Acute Ischemic Stroke
Jinkwon Kim (2017)
10.1161/STROKEAHA.110.579375
Antihypertensive Drug Use and Adherence After Stroke: Are There Sex Differences?
Nadia A Khan (2010)
10.1016/S0140-6736(16)30506-2
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
Martin O'Donnell (2016)
10.1001/jama.2015.10082
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.
Alessandro Biffi (2015)
10.1001/jama.297.2.177
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction.
Jeppe Nørgaard Rasmussen (2007)
10.1093/ije/dyv319
Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea.
Juneyoung Lee (2017)
10.1016/S0140-6736(15)01225-8
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad (2016)
10.1093/qjmed/hct121
Impact of antihypertensive medication adherence on blood pressure control in hypertension: the COMFORT study.
Kenzo Matsumura (2013)
10.1111/j.1365-2796.2009.02084.x
Better adherence to antihypertensive agents and risk reduction of chronic heart failure.
Sylvie Perreault (2009)
10.1161/HYP.0000000000000065
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Paul Kieran Whelton (2018)
10.5853/jos.2017.00164
Blood Pressure Management for Stroke Prevention and in Acute Stroke
Keun-Sik Hong (2017)
10.1161/STROKEAHA.115.010037
Predictive Factors for Rebleeding After Aneurysmal Subarachnoid Hemorrhage: Rebleeding Aneurysmal Subarachnoid Hemorrhage Study
Carlina E van Donkelaar (2015)
10.1038/sj.jhh.1001647
Blood pressure in acute intracerebral haemorrhage
Aida Hanum Ghulam Rasool (2004)
10.1097/01.hjh.0000187261.40190.2e
Rate and determinants of 10-year persistence with antihypertensive drugs
Boris L G van Wijk (2005)
Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications
김소연 (2016)
Hypertension Prevalence and Control Among Adults: United States, 2011-2014.
Sung Sug Sarah Yoon (2015)
10.1093/brain/awh587
Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms.
Marieke J. H. Wermer (2005)
10.1159/000346087
European Stroke Organization Guidelines for the Management of Intracranial Aneurysms and Subarachnoid Haemorrhage
Thorsten Steiner (2013)
10.1161/JAHA.117.006056
Antihypertensive Medication Adherence and Risk of Cardiovascular Disease Among Older Adults: A Population‐Based Cohort Study
Quanhe Yang (2017)
10.1161/CIRCULATIONAHA.104.490599
Epidemiology of uncontrolled hypertension in the United States.
Thomas J. Wang (2005)
10.7326/0003-4819-157-11-201212040-00538
Interventions to Improve Adherence to Self-administered Medications for Chronic Diseases in the United States
Meera Viswanathan (2012)
10.1186/1471-2458-14-281
The association between socioeconomic status and disability after stroke: Findings from the Adherence eValuation After Ischemic stroke Longitudinal (AVAIL) registry
Janet Prvu Bettger (2014)
10.1161/01.STR.24.12.1844
The J‐Curve Phenomenon in Stroke Recurrence
Katsumi Irie (1993)
10.1212/WNL.0b013e31822f0423
Secondary preventive medication persistence and adherence 1 year after stroke
Cheryl D Bushnell (2011)
10.1185/030079908X253843
The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke
Nancy S. Breekveldt-Postma (2008)
10.1016/j.jacc.2016.11.034
Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications.
Keith C Ferdinand (2017)
10.1161/HYPERTENSIONAHA.115.05463
Adherence With Antihypertensive Drug Therapy and the Risk of Heart Failure in Clinical Practice
Giovanni Corrao (2015)
10.1161/CIRCULATIONAHA.116.024073
Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics
Kyle B Walsh (2016)
10.1161/CIRCULATIONAHA.108.830299
Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients
Giampiero Mazzaglia (2009)
10.1159/000441085
Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study
Valery L Feigin (2015)
: are there sex differences ?
NS Breekveldt-Postma (2010)
10.1161/JAHA.115.002606
Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta‐Analysis of Controlled Trials
Todd M. Ruppar (2016)
10.1161/01.STR.0000130855.70683.c8
Effect of Untreated Hypertension on Hemorrhagic Stroke
Daniel Woo (2004)
10.1161/STROKEAHA.112.670877
State Differences in the Reporting of ‘Unspecified Stroke’ on Death Certificates: Implications for Improvement
Tain-Junn Cheng (2012)
10.1016/j.jash.2018.01.004
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Robert D. Brook (2018)
10.3988/jcn.2016.12.1.42
Validation of Stroke and Thrombolytic Therapy in Korean National Health Insurance Claim Data
Tai Hwan Park (2016)
10.1038/ki.2013.103
Adherence to antihypertensive agents improves risk reduction of end-stage renal disease.
Louise Roy (2013)
10.1161/HYPERTENSIONAHA.115.06731
Medication Adherence and the Risk of Cardiovascular Mortality and Hospitalization Among Patients With Newly Prescribed Antihypertensive Medications
Soyeun Kim (2016)
10.1177/1753944712444866
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin–angiotensin system blockers
Paolo Verdecchia (2012)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar